• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌肿瘤生长,无新生血管生成的形态学证据。

Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.

作者信息

Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, Gatter K C, Harris A L, Fox S, Buyse M, Pilotti S, Pierotti M, Rilke F

机构信息

Department of Histopathology, University College London, UK.

出版信息

Am J Pathol. 1997 Nov;151(5):1417-23.

PMID:9358768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1858069/
Abstract

Neoplastic growth is usually dependent on blood supply, and it is commonly accepted that this is provided by the formation of new vessels. However, tumors may be able to grow without neovascularization if they find a suitable vascular bed available. We have investigated the pattern of vascularization in a series of 500 primary stage I non-small-cell lung carcinomas. Immunostaining of endothelial cells has highlighted four distinct patterns of vascularization. Three patterns (which we called basal, papillary, and diffuse) have in common the destruction of normal lung and the production of newly formed vessels and stroma. The fourth pattern, which we called alveolar or putative nonangiogenic, was observed in 16% (80/500) of the cases and is characterized by lack of parenchymal destruction and absence of both tumor associated stroma and new vessels. The only vessels present were the ones in the alveolar septa, and their presence highlighted, through the whole tumor, the lung alveoli filled up by the neoplastic cells. This observation suggests that, if an appropriate vascular bed is available, a tumor can exploit it and grows without inducing neo-angiogenesis. This could have implications for strategies aimed at inhibiting tumor growth by vascular targeting or inhibition of angiogenesis.

摘要

肿瘤生长通常依赖血液供应,人们普遍认为这是通过新血管形成来实现的。然而,如果肿瘤找到合适的血管床,它们可能无需新生血管形成就能生长。我们研究了500例I期原发性非小细胞肺癌的血管化模式。内皮细胞免疫染色突出显示了四种不同的血管化模式。三种模式(我们称为基底型、乳头型和弥漫型)的共同特点是正常肺组织被破坏,以及新生血管和间质的形成。第四种模式,我们称为肺泡型或假定的非血管生成型,在16%(80/500)的病例中观察到,其特征是缺乏实质破坏,且不存在肿瘤相关间质和新血管。仅有的血管是肺泡隔中的血管,它们的存在通过整个肿瘤突出显示了被肿瘤细胞填满的肺泡。这一观察结果表明,如果有合适的血管床,肿瘤可以利用它并在不诱导新生血管生成的情况下生长。这可能对旨在通过血管靶向或抑制血管生成来抑制肿瘤生长的策略产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/bf4b253bdf0f/amjpathol00023-0237-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/ff44a0da219d/amjpathol00023-0235-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/e3c3dd86d216/amjpathol00023-0236-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/8dedda4e9d2f/amjpathol00023-0236-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/bf4b253bdf0f/amjpathol00023-0237-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/ff44a0da219d/amjpathol00023-0235-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/e3c3dd86d216/amjpathol00023-0236-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/8dedda4e9d2f/amjpathol00023-0236-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca9/1858069/bf4b253bdf0f/amjpathol00023-0237-a.jpg

相似文献

1
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.非小细胞肺癌肿瘤生长,无新生血管生成的形态学证据。
Am J Pathol. 1997 Nov;151(5):1417-23.
2
Patterns of angiogenesis in nonsmall-cell lung carcinoma.非小细胞肺癌中的血管生成模式
Cancer. 2001 Apr 15;91(8):1500-9.
3
'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.血管生成的“侵袭边缘与内部”(edvin)模式:血管生成因子与血管存活因子之间的相互作用决定了非小细胞肺癌的临床行为。
J Pathol. 2000 Oct;192(2):140-9. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH693>3.0.CO;2-R.
4
Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.层粘连蛋白α2链(黑素结合蛋白M链)在声门上癌、肺癌和乳腺癌血管生成中的分布以及血管内皮生长因子、碱性成纤维细胞生长因子(FGF-2)和转化生长因子β1基因的表达
J Pathol. 2001 Sep;195(2):197-208. doi: 10.1002/path.938.
5
Variation in vascular distribution in small lung cancers.小肺癌中的血管分布变化。
Lung Cancer. 2010 Jun;68(3):389-93. doi: 10.1016/j.lungcan.2009.07.006. Epub 2009 Aug 28.
6
Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.血管内皮生长因子与新生血管形成相关,并影响非小细胞肺癌的进展。
Clin Cancer Res. 1997 Jun;3(6):861-5.
7
Distinct angiogenic and non-angiogenic growth patterns of lung metastases from renal cell carcinoma.肾细胞癌肺转移独特的血管生成性和非血管生成性生长模式。
Histopathology. 2007 Sep;51(3):354-61. doi: 10.1111/j.1365-2559.2007.02800.x.
8
Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.血管内皮生长因子(VEGF)及其两种受体(VEGF-R1-Flt1和VEGF-R2-Flk1/KDR)在非小细胞肺癌(NSCLC)中的表达:与血管生成和生存的相关性
J Pathol. 1999 Aug;188(4):369-77. doi: 10.1002/(SICI)1096-9896(199908)188:4<369::AID-PATH381>3.0.CO;2-X.
9
Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice.在裸鼠中,血管生成和成纤维细胞增殖先于放射治疗后复发性肿瘤的形成。
Anticancer Res. 2002 Mar-Apr;22(2A):677-88.
10
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.使用新型基底膜成分LH39评估非小细胞肺癌中的血管成熟:与p53和血管生成因子表达的相关性
Cancer Res. 1999 Nov 1;59(21):5602-7.

引用本文的文献

1
Linking tumour angiogenesis and tumour immunity.将肿瘤血管生成与肿瘤免疫联系起来。
Nat Rev Immunol. 2025 Aug 14. doi: 10.1038/s41577-025-01211-z.
2
Recent advancements in lung cancer research: a narrative review.肺癌研究的最新进展:一篇综述。
Transl Lung Cancer Res. 2025 Mar 31;14(3):975-990. doi: 10.21037/tlcr-24-979. Epub 2025 Mar 27.
3
Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance.I-IIIA期肺鳞状细胞癌中不同类型的肿瘤微血管及其临床意义。

本文引用的文献

1
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.I期肺癌中的免疫细胞化学标志物:与预后的相关性。
J Clin Oncol. 1997 Aug;15(8):2858-65. doi: 10.1200/JCO.1997.15.8.2858.
2
Angiogenesis in primary lung cancer and lung secondaries.原发性肺癌和肺转移瘤中的血管生成
Eur J Cancer. 1996 Dec;32A(14):2494-500. doi: 10.1016/s0959-8049(96)00377-2.
3
Angiogenesis and metastasis.血管生成与转移
World J Clin Oncol. 2024 May 24;15(5):614-634. doi: 10.5306/wjco.v15.i5.614.
4
Vessel co-option: a unique vascular-immune niche in liver cancer.血管共选择:肝癌中一种独特的血管免疫微环境
Front Oncol. 2024 Apr 26;14:1386772. doi: 10.3389/fonc.2024.1386772. eCollection 2024.
5
Antiangiogenic-immune-checkpoint inhibitor combinations: lessons from phase III clinical trials.抗血管生成-免疫检查点抑制剂联合治疗:III 期临床试验的经验教训。
Nat Rev Clin Oncol. 2024 Jun;21(6):468-482. doi: 10.1038/s41571-024-00886-y. Epub 2024 Apr 10.
6
Mechanisms of angiogenesis in tumour.肿瘤血管生成的机制
Front Oncol. 2024 Mar 25;14:1359069. doi: 10.3389/fonc.2024.1359069. eCollection 2024.
7
The role of vasculature and angiogenesis in respiratory diseases.血管和血管生成在呼吸疾病中的作用。
Angiogenesis. 2024 Aug;27(3):293-310. doi: 10.1007/s10456-024-09910-2. Epub 2024 Apr 5.
8
The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy.血管重编程抑制作为一种癌症治疗的新兴策略。
Int J Mol Sci. 2024 Jan 11;25(2):921. doi: 10.3390/ijms25020921.
9
Prostate Cancer Microvascular Routes: Exploration and Measurement Strategies.前列腺癌微血管路径:探索与测量策略
Life (Basel). 2023 Oct 9;13(10):2034. doi: 10.3390/life13102034.
10
Therapeutic potential of vasculogenic mimicry in urological tumors.血管生成拟态在泌尿系统肿瘤中的治疗潜力
Front Oncol. 2023 Sep 21;13:1202656. doi: 10.3389/fonc.2023.1202656. eCollection 2023.
Eur J Cancer. 1996 Dec;32A(14):2451-60. doi: 10.1016/s0959-8049(96)00389-9.
4
Prognostic value of angiogenesis in operable non-small cell lung cancer.可手术切除的非小细胞肺癌中血管生成的预后价值
J Pathol. 1996 May;179(1):80-8. doi: 10.1002/(SICI)1096-9896(199605)179:1<80::AID-PATH547>3.0.CO;2-X.
5
Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis.乳腺癌血管生成的定量分析及预后价值:微血管密度、Chalkley计数与计算机图像分析的比较
J Pathol. 1995 Nov;177(3):275-83. doi: 10.1002/path.1711770310.
6
Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer.肿瘤血管生成与非小细胞肺癌的组织学类型及转移相关。
Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2157-62. doi: 10.1164/ajrccm.152.6.8520790.
7
The histologic grading of cancer.癌症的组织学分级。
Cancer. 1995 Jan 1;75(1 Suppl):406-21. doi: 10.1002/1097-0142(19950101)75:1+<406::aid-cncr2820751322>3.0.co;2-w.
8
Intratumor microvessel density as a prognostic factor in cancer.肿瘤内微血管密度作为癌症的一个预后因素。
Am J Pathol. 1995 Jul;147(1):9-19.
9
Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.乳腺癌中肿瘤血管生成测定的临床重要性:远不止一种新的预后工具。
J Clin Oncol. 1995 Mar;13(3):765-82. doi: 10.1200/JCO.1995.13.3.765.
10
Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue.舌鳞状细胞癌中的肿瘤血管生成、p53抗原与颈部转移
Otolaryngol Head Neck Surg. 1994 Oct;111(4):417-22. doi: 10.1177/019459989411100405.